Stockreport

MorphoSys AG Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update

MorphoSys AG - American Depositary Shares  (MOR) 
PDF – Entered into Business Combination Agreement to be acquired by Novartis for € 68.00 per share in cash or € 2.7 billion equity value– Sold all tafasitamab rights worldwi [Read more]